HORIZON 2020 | Santé, Changement Démographique & Bien-être - HORIZON 2020 Tunisia
←
→
Transcription du contenu de la page
Si votre navigateur ne rend pas la page correctement, lisez s'il vous plaît le contenu de la page ci-dessous
Santé,
HORIZON 2020 | Changement
Dr Yosr Z. HAFFANI PCN Santé
Démographique
Faculté de Médecine de Sfax, Université de Sfax 23 Novembre 2017 & Bien-être
HORIZON 2020 = 3 PRIORITÉS
EXCELLENCE
LEADERSHIP
INDUSTRIEL
DEFIS
SOCIETAUX
SCIENTIFIQUE
Répondre
aux
défis
sociétaux
Posi2onner
l’UE
comme
Favoriser
plus
d’innova2on
et
de
l’UE
(vieillissement
pôle
d’Excellence
renforcer
le
leadership
démographique,
changement
scien2fique
mondial
industriel
de
l’UE
dans
le
clima2que,
sécurité,
monde
développement
durable,
…)
5
HORIZON 2020
EXCELLENCE
PRIMAUTE
SCIENTIFIQUE
INDUSTRIELLE
DEFIS
SOCIETAUX
ERC
13md€
Technologies
clefs
13,6md
7,5md€
European
Research
génériques
€
Santé
Council
TIC,
microélectronique,
photonique,
nanotechnologies,
matériaux
Bioéconomie
3,9md€
avancés,
Systèmes
de
produc>on,
biotechnologies
Espace
Energie
5,9md€
FET
6md€
Future
Emerging
6,3md€
Technologies
Transport
Changement
3,1md€
Marie
Curie
2,7md€
Accès
au
616m€
financement
à
clima2que
Infrastructures
2,5md€
risque
Sociétés
1,3md€
Innova)on
dans
2,8md€
inclusives
les
PME
Sécurité
1,7md€
Diffusion
de
l’excellence
et
élargissement
de
la
par2cipa2on
(817m€)
Ins2tut
Européen
d’Innova2on
et
Technologie
(EIT)
(2,7md€)
Science
pour
et
avec
la
société
(462m€)
Centre
commun
de
recherche
(JRC)
Euratom
6
CONTEXTE DU DÉFI SANTÉ • Changement démographique • Accroissement du fardeau des maladies non-‐transmissibles/« lifestyle » • Augmenta2on du coût de la santé & de la pression sur les systèmes de santé • Augmenta2on des coûts du développement des médicaments, vaccins, disposi2fs médicaux… • Insuffisance d’évidences sur les avantages et l’efficacité, des approches et pra)ques actuelles à Promouvoir le vieillissement ac)f et en bonne santé à Favoriser une approche « tout au long de la vie » à volonté de « scale-‐up » la recherche et amplifier sur l’existant à Soutenir le transfert vers la clinique à Réduire les inégalités dans le domaine de la santé à U2lisa2on des infrastructures européennes
Main objectives:
‘Promoting healthy ageing and personalised healthcare'.
BUDGET 2018
:
396
M€
2019:
517
M€
2020
:
490
M€
HEALTH 2014-2020
€ 7.472 bil.
The indicative budgets for the calls announced are listed in Work Programme.
RÈGLES DE PARTICIPATION DES DÉFIS
• Toute entité légale peut participer
• 3 entités légales de 3 Etats-membres ou Etats associés différents (exception
pour outils PME - mono bénéficiaire et action de coordination)
• Entités légales financées : établies dans les Etats-membres ou Etats associés +
Exception unique du défi santé: USA financés
• Pour les Etats tiers : certains « low-income » sont financés (cf liste ci-dessous ) – ou expressément prévu dans le
programme de travail
http://ec.europa.eu/research/participants/data/ref/h2020/grants_manual/hi/3cpart/h2020- hi-3cpart_en.pdf
• Certains pays ont des programmes nationaux ( ex: Mexique, Australie, Canada, …)
Des critères d’évaluation simples et uniformes
Excellence – Impact – Mise en œuvre
http://ec.europa.eu/research/participants/data/ref/h2020/wp/2014_2015/annexes/h2020-
wp1415-annex-h-esacrit_en.pdf
NE PAS NÉGLIGER LES ASPECTS IMPORTANTS
• Implica2on
des
PME
• Aspect
éthique
(expérimenta2on
humaine
et
animale
)
• Aspect
genre
dans
le
projet
et
dans
le
consor2um
• Implica2on
des
ONG,
associa)ons
de
pa)ents
et
acteurs
de
la
société
civile
• No2on
de
data
management
(+
open
access
et
open
data
volontaire)
(Data
Management
Plan
are
incited
to
iden>fy
the
exis>ng
European
research
data
infrastructures
that
may
be
used
and
how
these
may
be
mobilised,
in
par>cular
for
long-‐term
data
cura>on
and
preserva>on)
TYPE
OF
ACTIVITIES
RIA-‐
Research
and
Innova)on
Ac)ons
100%
funding
rate
IA-‐
Innova)on
Ac)ons
36-‐48
months
70%
funding
rate
2-‐5
mil.
€
30-‐36
months
Consor)um
of
min.
3
partners
from
3
MS
or
AC
2-‐5
mil.
€
Consor)um
of
min.
3
partners
from
3
MS
or
AC
CSA-Coordination and Support Actions
100% funding rate
12-30 months
0.5 – 2 mil.
€
1 legal entity
CALENDRIER PUBLICATION, SOUMISSION ET ÉVALUATION
Work
Programme
2018-‐2020
§ Critères
d’évalua2on:
Il
existe
des
seuils
de
passage
Passage
à
1
Etape
RIA
:
Seuils
:
Excellence
,
Impact,
Implementa2on
=
Total:
13/15
§ «
Time
to
Grant
»:
8
mois
(soumission
-‐
résultat
5
mois
-‐
phase
de
négo2a2on
3
mois)
OU TROUVER L ES CALLS? PARTICIPANT PORTAL HTTP://EC.EUROPA.EU/RESEARCH/PARTICIPANTS/PORTAL/DESKTOP/EN/OPPORTUNITIES/I NDEX.HTML
OU TROUVER L ES CALLS? PARTICIPANT PORTAL HTTP://EC.EUROPA.EU/RESEARCH/PARTICIPANTS/PORTAL/DESKTOP/EN/OPPORTUNITIES/I NDEX.HTML
DÉFI SANTE – WORK PROGRAMME 2018-2020
Better Health & Care, Economic
Growth & Sustainable Health
DG
Research
Technological
Development
RTD
Digital transformation in
Health and Care
DG
Communica)on
Network
Trusted digital solutions and Content
&
Technology
Cybersecurity in Health and Care
CNECT
(TIC)
IPr Inducement PrizeCOMMENT LIRE UNE LIGNE D’APPEL?
Area:
Personalised
Medicine
Thème
Date du call
SC1-‐HCO-‐01-‐2018:
Ac)ons
in
support
of
the
Interna)onal
Consor)um
for
Personalised
Medicine
[RTD]
Titre et date du
Specific
challenge:
call
Popula2on
cohorts
are
invaluable
resources
to
obtain
detailed
descrip2on
of
individual
biological
varia)ons
in
connec)on
with
a
variety
of
environmental,
[…]
However,
the
lack
of
integra2on
of
these
cohorts
hampers
the
op)mal
exploita)on
of
these
resources,
essen2al
to
underpin
Défi
spécifique
à
and
facilitate
the
development
of
stra)fied
and
personalised
medicine.
relever
jus)fica)on
Scope:
The
proposals
should
aim
at
maximizing
the
exploita2on
of
cohorts
by
bringing
together
na2onal
and/or
European
cohorts
with
common
scien2fic
Périmètre
de
[…]
European
infrastructures
and
addi2onal
collabora2ons
with
relevant
interna2onal
ini2a2ves
are
encouraged.
Proposals
should
also
engage
with
l’ac)on
à
relevant
interna2onal/na2onal/regional
authori2es
to
ensure
that
findings
are
implemented
and
translated
into
health
policy.
adresser
The
Commission
considers
that
proposals
reques2ng
a
contribu2on
from
the
EU
of
between
EUR
8
and
10
million
would
allow
this
specific
Indica)on
challenge
to
be
addressed
appropriately.
Nonetheless,
this
does
not
preclude
submission
and
selec2on
of
proposals
reques2ng
other
amounts.
Budget
Expected
impact:
Expected
impacts
include
one
of
or
a
combina2on
of
the
following
point(s):
Impact
•Contribute
to
providing
novel
informa2on
on
health
maintenance,
onset
and
course
of
diseases,
or
popula2on
stra2fica2on,
with
a
ajendu
en
view
to
tailor
diagnosis
or
to
op2mise
treatment.
lien
avec
le
• Op2mise
the
use
of
popula2on
cohorts
in
defining/improving
clinical
prac2ce
and
public
health
policy.
défi
• Make
major
conceptual,
methodological
and
analy2cal
contribu2ons
towards
integra2ve
cohorts
Type
of
ac)on:
RIA
Type
de
projet
DOSSIER
DE
CANDIDATURE
:
CONTENU
WORK PROGRAMME 2018-2020
1- Excellence 3- Implémentation
-Objectifs -Programme de travail
-Relations avec le -Management (structure et
programme de travail procédures)
-Concept et approche -Le consortium dans son
-Ambition ensemble
-Les ressources
2- Impact 4 – Le consortium
-Impacts attendus -Participants
-Mesures pour -Tierce-parties
maximiser l’impact 5- Ethique et sécuritéCHAQUE W ORK P ACKAGE E ST D ÉCRIT E N D ÉTAIL FICHE WORK PACKAGE
ENCHAINEMENT
LOGIQUE
D’UNITÉS
WORK PACKAGES
16TROUVER DES PARTENAIRES
Ø U)lisez
d'abord
VOTRE
réseau
• U)lisez
les
réseaux
de
spécialistes
des
projets
européens
§ Le
service
de
fisorhealth:
www.fisorhealth.eu
§ Rapprochez
vous
des
organismes/universités/CHU
§ Si
vous
cherchez
des
PME
u2lisez
les
réseaux
régionaux
et
via
le
PCN
PME
§ Cordis
portal:
htp://cordis.europa.eu/
Trouver
ce
qui
a
été
financé
• Par)cipez
aux
évènements
autour
de
Horizon2020
ou
interna)onaux
§ Infodays
§ Brokerage
event
MAIN RESEARCH PRIORITIES FOR 2018-2020 Call 1. – Better Health and Care, Economic Growth & Sustainable Health Systems 1.1 Personalised Medicine 1.2 Innovative health and care industry 1.3 Infectious diseases and improving global health 1.4. Innovative health and care systems - Integration of care 1.5 Decoding the role of the environment for health and well-being Call 2. – Digital transformation in Health and Care Call 3. – Trusted digital solutions and Cybersecurity in Health and Care
DÉFI SANTE – WP 2018-2020
Better Health and Care (BHC)
Call 1. "Better Health and care, economic growth and sustainable health systems”
1.1 Personalised Medicine I
SC1-BHC-03-2018: Exploiting research results and potential of the human microbiome for personalised prediction and
prevention of disease RIA 13 & 14 M€
SC1-BHC-04-2018: Rare Disease Joint Programme Co-Fund COFUND (European Joint Programme) 50 M€
SC1-BHC-05-2018: International flagship collaboration with Canada for human data storage, integration and sharing for
developing personalised medicine approaches RIA 6 M€
over 4 yearsDÉFI SANTE – WP 2018-2020
Better Health and Care (BHC)
Call 1. "Better Health and care, economic growth and sustainable health systems”
1.1 Personalised Medicine II
SC1-BHC-01-2019: Understanding causative mechanisms in co-morbidities RIA 4 & 6 M€
SC1-BHC-02-2019: Systems approaches for the discovery of combinatorial therapies RIA 4 & 6 M€DÉFI SANTE – WP 2018-2020
Better Health and Care (BHC)
Call 1. "Better Health and care, economic growth and sustainable health systems”
1.1 Personalised Medicine III
Coordination Activities
SC1-HCO-01-2018-2019-2020: Actions in support of the International Consortium for Personalised Medicine
CSA 1.5 & 2 M€
SC1-HCO-02-2018: Data integration and data-driven in-silico models for enabling personalised medicine - a European
standardization framework CSA 1.5 & 2 M€
SC1-HCO-04-2018: ERA-NET to support the Joint Programming in Neurodegenerative Diseases strategic plan (JPND)
ERA-NET Cofund 5 & 6 M€DÉFI SANTE – WP 2018-2020
Better Health & Care (BHC)
Call 1. "Better Health and Care, economic growth and sustainable health systems”
1.2 Innovative Health & Care Industry
SC1-BHC-09-2018: Innovation platforms for advanced therapies of the future RIA 6-8 M€
SC1-HCO-05-2018: Strengthen Regulatory Sciences and support for successful regulatory Scientific Advice
CSA 1-2 M€
SC1-BHC-07-2019: Regenerative medicine: from new insights to new applications RIA 6-8 M€
SC1-BHC-10-2019: Innovation Procurement: Next generation sequencing (NGS) for routine diagnosis
RIA 12-15 M€DÉFI SANTE – WP 2018-2020
Better Health and Care (BHC)
Call 1. "Better Health and Care, economic growth and sustainable health systems”
1.3 Infectious diseases and improving global health I
SC1-BHC-15-2018: New anti-infective agents for prevention and/or treatment of neglected infectious diseases (NID)
RIA 5 -10 M€
SC1-BHC-16-2018: Global Alliance for Chronic Diseases (GACD) 1 RIA 1 - 3 M€
Focus on Hypertension/Diabete
SC1-BHC-21-2018: Research on HIV and/or tuberculosis in patients with mono-, co-infections or comorbidities in the contest of
fostering the collaboration with (alt. widening the participants to) Russia and other countries in the Central- and Eastern
European region RIA 2 - 4 M€DÉFI SANTE – WP 2018-2020
Better Health and Care (BHC)
Call 1. "Better Health and Care, economic growth and sustainable health systems”
1.3 Infectious diseases and improving global health II
Coordination Activities
SC1-HCO-06-2018: Global Research Collaboration for Infectious Disease Preparedness (GloPID-R), Establishment of an
International Network of Research Centres on Global Governance for Infectious Disease Preparedness
CSA 1.5 - 2 M€
SC1-HCO-09-2018: Building international efforts on cohorts CSA 1.5 - 2 M€
SC1-HCO-10-2018: Coordinating European brain research and developing global initiatives CSA 1 - 2 M€
SC1-HCO-11-2018: Strategic collaboration in healthcare research and innovation between EU & China
CSA 1.5 - 2 M€DÉFI SANTE – WP 2018-2020
Better Health and Care (BHC)
Call 1. "Better Health and Care, economic growth and sustainable health systems”
1.3 Infectious diseases and improving global health III
SC1-BHC-13-2019: Preparedness research for (Re-) Emerging Infectious Diseases RIA 12-15 M€
SC1-BHC-14-2019: Stratified host-directed approaches to improve prevention &/or treatment of infectious diseases
RIA 6-10 M€
SC1-BHC-18-2019: EU-CELAC collaboration for research on non-communicable diseases RIA 1-3 M€
SC1-BHC-19-2019: Implementation research for maternal and child health RIA 2-4 M€
SC1-HCO-08-2019: Creation of a European wide sustainable clinical research networks for infectious diseases
CSA 2-3 M€DÉFI SANTE – WP 2018-2020
Better Health and Care (BHC)
Call 1. "Better Health and Care, economic growth and sustainable health systems”
1.4. Innovative health and care systems - Integration of care
SC1-BHC-23-2018: Novel patient-centred approaches for survivorship, palliation & end-of-life care
RIA 3-4M€
SC1-BHC-26-2018: HTA research to support evidence-based healthcare RIA 8-10M€
SC1-HCO-12-2018: Innovation in health care - towards using pre-commercial procurement & public procurement
of innovative solutions in health care systems CSA 2-3M€
SC1-BHC-22-2019: Mental health in the workplace RIA 2-4M€
SC1-BHC-25-2019: Demonstration pilots for implementation of Personalised Medicine in health care
RIA 15-20M€DÉFI SANTE – WP 2018-2020
Better Health and Care (BHC)
Call 1. "Better Health and Care, economic growth and sustainable health systems”
1.5 Decoding the role of the environment for health and well-being
SC1-BHC-27-2018: Endocrine disrupters – research for better regulation and improved understanding of health effects
RIA 4-6M€
SC1-HCO-13-2018: Setting the Priorities for the European Environment and Health Agenda
CSA 1.5-2M€
SC1-BHC-28-2019: The Human Exposome Project: a toolbox for assessing and addressing the impact of environment and
climate change on health RIA 8-12M€DÉFI SANTE – WP 2020
EUR 490 million Better Health and Care (BHC)
Call 1. "Better Health and Care, economic growth and sustainable health systems”
1.1 Personalised Medicine
SC1-BHC-06-2020: Digital diagnostics – developing tools for clinical decisions integrating in vitro and in vivo
diagnostics
SC1-HCO-03-2020: Improving EU-13 participation in EU-supported health research programmes CSA
1.2 Innovative Health & Care Industry
SC1-BHC-08-2020: New therapies for Non Communicable Diseases
SC1-BHC-11-2020: New, animal-free regulatory test methods for human safety testing at the horizon of 2030
SC1-BHC-12-2020: Boosting the translation of results of health research into validated, innovative applicationsDÉFI SANTE – WP 2020
EUR 490 million Better Health and Care (BHC)
Call 1. "Better Health and Care, economic growth and sustainable health systems”
1.3 Infectious diseases and improving global health
SC1-BHC-17-2020: Global Alliance for Chronic Diseases (GACD) 2
SC1-BHC-20-2020: Using pre-commercial procurements and public procurement of innovative solutions in health
care systems to: - reduce the risk of hospital-acquired infections and/or - improve integrated care
1.4. Innovative health and care systems - Integration of care
SC1-BHC-24-2020: Healthcare interventions for the management of the elderly multimorbid patient
1.5 Decoding the role of the environment for health and well-being
SC1-BHC-29-2020: The Human Exposome Project: a toolbox for assessing and addressing the impact of
environment and climate change on healthDÉFI SANTE – WP 2018-2020
IPr Inducement Prize
Other Actions 2018-2019
Prize 1 (2019) – Horizon Prize on novel solutions to reduce the spread of AMR in the environment 2M€
Prize 3 (2019) – Exemplary application of personalised medicine approaches at a local or regional level
1M€
Prize 5 (2019) - Novel tool(s) to limit the use of test animals in biomedical sciences and safety testing
– RTD – Inducement Prize 1M€
Prize 2 (2020) - Surgical care in resource-poor settings
Prize 6 (2020) - Implantation of smart medical devices to (re-) establish neural &/or neuronal functionMERCI POUR VOTRE ATTENTION
Dr. Yosr HAFFANI
Maître-Assistante
NCP Santé, Changement Démographique et Bien-être
health@horizon2020tunisia.org
31Vous pouvez aussi lire
